Glycemic Control and Heart Failure Among Adult Patients With Diabetes
Top Cited Papers
- 5 June 2001
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Circulation
- Vol. 103 (22), 2668-2673
- https://doi.org/10.1161/01.cir.103.22.2668
Abstract
Background —Glycemic control is associated with microvascular events, but its effect on the risk of heart failure is not well understood. We examined the association between hemoglobin (Hb) A Ic and the risk of heart failure hospitalization and/or death in a population-based sample of adult patients with diabetes and assessed whether this association differed by patient sex, heart failure pathogenesis, and hypertension status. Methods and Results —A cohort design was used with baseline between January 1, 1995, and June 30, 1996, and follow-up through December 31, 1997 (median 2.2 years). Participants were 25 958 men and 22 900 women with (predominantly type 2) diabetes, ≥19 years old, with no known history of heart failure. There were a total of 935 events (516 among men; 419 among women). After adjustment for age, sex, race/ethnicity, education level, cigarette smoking, alcohol consumption, hypertension, obesity, use of β-blockers and ACE inhibitors, type and duration of diabetes, and incidence of interim myocardial infarction, each 1% increase in Hb A Ic was associated with an 8% increased risk of heart failure (95% CI 5% to 12%). An Hb A Ic ≥10, relative to Hb A Ic Conclusions —These results confirm previous evidence that poor glycemic control may be associated with an increased risk of heart failure among adult patients with diabetes.This publication has 30 references indexed in Scilit:
- Effects of an Angiotensin-Converting–Enzyme Inhibitor, Ramipril, on Cardiovascular Events in High-Risk PatientsThe New England Journal of Medicine, 2000
- Excess maternal transmission of type 2 diabetes. The Northern California Kaiser Permanente Diabetes Registry.Diabetes Care, 1999
- The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trialThe Lancet, 1999
- Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)The Lancet, 1998
- How Have Patients Reacted to the Implications of the DCCT?Diabetes Care, 1996
- Cardiac consequences of diabetes mellitusClinical Cardiology, 1995
- Diabetic Cardiomyopathy: A unique entity or a complication of coronary artery disease?Diabetes Care, 1995
- Diabetic cardiomyopathyAmerican Heart Journal, 1989
- Increased levels of messenger ribonucleic acid for apolipoprotein E in the spleen of probucol-treated rabbitsThe American Journal of Cardiology, 1988
- Role of diabetes in congestive heart failure: The Framingham studyThe American Journal of Cardiology, 1974